Skip to Content

Cassava Sciences Inc SAVA Stock Quote

| Rating as of

NASDAQ: SAVA

Market Closed

| Currency in USD

  • Last Close 17.54
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 17.45  –  17.96
  • Year Range 16.55  –  50.77
  • Market Cap 736.1537 Mil
  • Volume / Avg 353,168.0 /  927,951.2
  • Price / Sales
  • Price / Book 4.10
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis SAVA

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SAVA

Company Profile SAVA

Business Description

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Contact
6801 N. Capital of Texas Highway, Suite 300, Building 1
Austin, TX, 78731
Industry Biotechnology
Employees 26

Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.

Cassava Sciences Inc

XNAS: SAVA

Aclaris Therapeutics Inc

XNAS: ACRS

Castle Biosciences Inc

XNAS: CSTL

Biora Therapeutics Inc Ordinary Shares

XNAS: BIOR
Price
17.546.6516.522.13
Currency
USDUSDUSDUSD
Change
−$0.14 (0.79%) −$0.17 (2.49%) −$0.14 (0.84%) −$0.06 (2.74%)
Market Cap
736.15 Mil470.78 Mil442.90 Mil49.69 Mil
Industry
Biotechnology Diagnostics & Research Diagnostics & Research Biotechnology
Sector
Healthcare
Healthcare
Healthcare
Healthcare

* Trading data in this section is delayed by at least 15 minutes.

FAQs for Cassava Sciences Inc Stock

No. SAVA does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SAVA’s market cap is 736.15 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SAVA’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

SAVA’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SAVA’s historical performance against its industry peers and the overall market.